Category: Biopharmaceuticals
Global Biopharmaceuticals
-
2025 Global Forecast for Biopharmaceutical Cmo Services Market (2026-2031 Outlook)-High Tech Outlook Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
2025 Global: Biologics And Biosimilars Market - Innovative Markets Forecast (2031) report
... industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is the only market ... Read More
-
2025 Global Forecast for Bioreactor Market (2026-2031 Outlook)-High Tech Outlook Report
... service category is within the NAICS Medical Device Mfg. industry. The product or service category is within the NAICS Medical Device Mfg. industry. The global market is expected to increase from USD xx billion in ... Read More
-
PEGylated Proteins Market Report by Product (Consumables, Services), Protein Type (Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VII, and Others), Application (Cancer Treatment, Hepatitis, Chronic Kidney Diseases, Hemophilia, Multiple Sclerosis, Gastrointestinal Disorders, and Others), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2025-2033
... End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2025-2033 The global PEGylated proteins market size reached USD 1.4 Billion in 2024. Looking forward, IMARC Group expects the market ... Read More
-
Global High Potency APIs Market Size study, by Type (Innovative, Generic), by Type of Synthesis (Synthetic, Biotech, Biosimilars, mAbs, Vaccines), by Manufacturers (Captive, Merchant), by Application (Oncology, Hormonal Imbalance, Glaucoma) and Regional Forecasts 2022-2032
... global High Potency APIs (HPAPIs) market is currently valued at approximately USD 26.97 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 10.10% during the forecast period from ... Read More
-
Global Animal Health Market Size Study, by Product (Biologics, Pharmaceuticals, Others), Animal Type, Distribution Channel, End Use, and Regional Forecasts 2022-2032
... and is anticipated to grow at a robust compound annual growth rate (CAGR) of 9.0% over the forecast period from 2024 to 2032. This rapid expansion highlights the critical role animal health plays in ensuring ... Read More
-
Global Biopharmaceutical Process Analytical Technology Market Size Study, by Technology (LC, GC, MS, qPCR, NGS, NMR, Raman, IR Spectroscopy), Product (Analyzer, Sensor, Software), Application (Vaccine, Biologics, CGT), End User, and Regional Forecasts 2022-2032
... Biopharmaceutical Process Analytical Technology Market, valued at approximately USD 1.03 billion in 2023, is projected to grow at an impressive compound annual growth rate (CAGR) of 16.00% over the forecast period 2024-2032. This robust growth ... Read More
-
2025 Global Forecast for Biologics Safety Testing Market (2026-2031 Outlook)-High Tech Outlook Report
... service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in 2026 to ... Read More
-
2025 Global Forecast for Biosimilar Contract Manufacturing Market (2026-2031 Outlook)-High Tech Outlook Report
... service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in 2026 to ... Read More
-
2025 Global Forecast for Biologics Contract Development Market (2026-2031 Outlook)-High Tech Outlook Report
... service category is within the NAICS Medical Device Mfg. industry. The product or service category is within the NAICS Medical Device Mfg. industry. The global market is expected to increase from USD xx billion in ... Read More
-
Psoriasis Biosimilars Market Forecasts to 2030 – Global Analysis By Product (Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Rituximab Biosimilars, Etanercept Biosimilars and Other Products), Therapy Type, Application, End User and By Geography
... Stratistics MRC, the Global Psoriasis Biosimilars Market is accounted for $10.27 billion in 2024 and is expected to reach $25.31 billion by 2030 growing at a CAGR of 12.2% during the forecast period. Psoriasis biosimilars ... Read More
-
Clinical Trials Outsourcing Market Size, Share, and Analysis, By Phase (Phase I, Phase II, Phase III, Phase IV), By Application (Cancer, Cardiovascular Diseases, Nervous System Diseases, Infectious Diseases, Musculoskeletal Disease, Gastroenterology Diseases, and Others), By Services Type (Protocol Designing, Site Identification, Patient Recruitment, Laboratory Services, Bioanalytical Testing Services, Clinical Trial Data Management Services, and Others), By End-User (Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, and Others), By Region (North America, Europe, Asia-Pacific, and Rest of the World), And Regional Forecast 2024-2034
... Services Type (Protocol Designing, Site Identification, Patient Recruitment, Laboratory Services, Bioanalytical Testing Services, Clinical Trial Data Management Services, and Others), By End-User (Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, and Others), By Region (North America, ... Read More
-
Global Perfusion Bioreactors Market Growth 2025-2031
... 2031. Perfusion is a means to maintain a cell culture bioreactor in which equivalent volumes of media are simultaneously added and removed from the reactor while the cells are retained in the reactor. Perfusion bioreactors ... Read More
-
Global Biologics Contract Development and Manufacturing Organization (CDMO) Market 2025-2029
... the forecast period. The report on the biologics contract development and manufacturing organization (CDMO) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around ... Read More
-
Global Avastin (Bevacizumab) Biosimilars Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Avastin (Bevacizumab) is a medication used to treat a number of types of ... Read More
-
Global Avastin (Bevacizumab) Biosimilars Market Growth 2024-2030
... the Avastin (Bevacizumab) Biosimilars is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Avastin (Bevacizumab) ... Read More
-
Global G-CSF Biosimilars Market Growth 2024-2030
... Biosimilars is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global G-CSF Biosimilars market. G-CSF Biosimilars ... Read More
-
Global HGH Biosimilars Market Growth 2024-2030
... Biosimilars is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global HGH Biosimilars market. HGH Biosimilars ... Read More
-
Biologics Fill Finish Services Market by Type of Primary Packaging Container (Ampoules, Cartridges, Syringes and Vials), Type of Biologic Manufactured (Antibodies, Cell Therapies, Gene Therapies, Oligonucleotides, Recombinant Proteins, Vaccines and Other Biologics), Scale of Operation (Preclinical / Clinical and Commercial), Therapeutic Area (Autoimmune Disorders, Cardiovascular Disorders, Infectious Diseases, Metabolic Disorders, Oncological Disorders and Other Disorders), End-users (Pharmaceutical / Biopharmaceutical Companies and Contract Manufacturing Organizations / Others), Type of Player (Industry and Non-Industry), Company Size (Small, Mid-sized and Large) and Key Geographical Regions (North America (US, Canada and Mexico), Europe (Austria, France, Germany, Italy, Spain, Switzerland, UK and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea and Rest of Asia-Pacific) and Rest of the World (Argentina, Brazil, Iran, Israel and Other Countries)): Industry Trends and Gl
... (Preclinical / Clinical and Commercial), Therapeutic Area (Autoimmune Disorders, Cardiovascular Disorders, Infectious Diseases, Metabolic Disorders, Oncological Disorders and Other Disorders), End-users (Pharmaceutical / Biopharmaceutical Companies and Contract Manufacturing Organizations / Others), Type of Player (Industry ... Read More
-
Global Insulin Biosimilars Market Growth 2024-2030
... Insulin Biosimilars is forecast to a readjusted size of US$ 1858.4 million by 2030 with a CAGR of 3.6% during review period. The research report highlights the growth potential of the global Insulin Biosimilars market. ... Read More
-
Hydrophobic Interaction Chromatography Market By Product and Service (Product, Service), By Sample type (Monoclonal antibodies, Vaccines, Cell culture sample, Plasma and serum sample, Others), By Application (Protein and antibody purification, Vaccine development, Drug discovery, Food and dietary supplement development), By End user (Pharmaceutical and biopharmaceutical companies, Contract research organizations and contract manufacturing organizations, Research and academic institutes, Others): Global Opportunity Analysis and Industry Forecast, 2024-2033
... and dietary supplement development), By End user (Pharmaceutical and biopharmaceutical companies, Contract research organizations and contract manufacturing organizations, Research and academic institutes, Others): Global Opportunity Analysis and Industry Forecast, 2024-2033 The hydrophobic interaction chromatography market ... Read More
-
Global Monoclonal antibodies (mAbs) Biosimilars Market Growth (Status and Outlook) 2024-2030
... With growing demand in downstream market, the Monoclonal antibodies (mAbs) Biosimilars is forecast to a readjusted size of US$ 5256.8 million by 2030 with a CAGR of 2.0% during review period. The research report highlights ... Read More
-
Biologics Contract Development Market Report: Trends, Forecast and Competitive Analysis to 2030
... disorder, cardiovascular disorder, and hematological disorder markets. The global biologics contract development market is expected to reach an estimated $40.9 billion by 2030 with a CAGR of 11.5% from 2024 to 2030. The major drivers ... Read More
-
Global Biosimilars Insulin Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Biosimilars is a biological product designed to have similar active properties to the one that ... Read More
-
Rare Disease Treatment Market Assessment, By Drug Type [Biologics, Biosimilars, Small Molecules], By Patient [Adult, Pediatric, Geriatric], By Therapeutic Area [Oncology, Hematology, Neurology, Endocrinology, Cardiovascular, Respiratory, Immunotherapy, Infectious Diseases, Others], Mode of Administration [Oral, Injectable, Others], By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities and Forecast, 2017-2031F
... Others], By Distribution Channel [Hospital Pharmacy, Retail Pharmacy, Online Pharmacy], By Region, Opportunities and Forecast, 2017-2031F Global hemophilia market is projected to witness a CAGR of 5.50% during the forecast period 2024-2031, growing from USD ... Read More
Research Assistance
